COVID-19*
Similar to MERS, SARS and the common cold, the novel coronavirus disease (COVID-19) was first detected in Wuhan, China, in December 2019, and has spread rapidly throughout China and the world.
3%
is the estimated mortality rate of COVID-19 infection
98%
of patients with COVID-19 infection presented with fever symptoms and later 55% of the patients developed dyspnea and 66% developed lymphopenia
76%
of patients presented with cough and 44% also had myalgia/fatigue with COVID-19 infection
2 days to 2 weeks
is the estimated incubation period after exposure according to the Centers for Disease Control and Prevention (CDC)
774
is the number of deaths across the world from SARS; COVID-19 deaths have now exceeded that number with over 1,800**
$675 million
is the amount needed for new coronavirus preparedness and a global response plan covering the months of February through April 2020 according to World Health Organization (WHO) International
rRT-PCR
or reverse real-time transcription polymerase chain reaction assay is the CDC prescribed test for labs to use for COVID-19 detection
